Waystar launches autonomous AI agents to contest US healthcare insurance claims

American software company Waystar has introduced artificial intelligence agents capable of reading insurance rejections, applying specific payer rules, and resubmitting denied healthcare claims without human intervention. The company characterizes the release as the first fully autonomous resubmission tool in the sector, leveraging a network that processes more than 7.5 billion healthcare payment transactions annually and reaches roughly 60% of American patients.

The technology targets a specific financial friction in the United States, where insurers eventually pay roughly 70% of initially rejected claims only after medical providers spend significant resources resubmitting them. The firm states that early adopters achieved a 75% reduction in analysis time and anticipate a 25% drop in documentation review, while acknowledging these figures might fluctuate and the latter metric remains projected.

The business also acknowledges operational risks, flagging potential variability in AI claims-matching accuracy across different payers. Furthermore, the system faces structural vulnerability if insurers alter the appeals and recoupment processes the agents were originally designed to navigate.

This aggressive automation of billing disputes underscores a fundamental divergence in how Europe and America manage healthcare administration. While the United States is deploying software to argue with insurers at massive scale, European regulators have focused on legislating the argument out of existence.

In Germany, the law strictly limits how many hospital invoices a sickness fund can send for medical audit each quarter, capping the rate at 5%, 10%, or 15% based on previous review survival rates. Additionally, a flat €400 surcharge applied since December 2024 penalizes hospitals when an audit reduces an invoice, effectively placing a financial ceiling on prolonged billing disputes.

The European Union’s AI Act classifies risk assessment and pricing in health insurance as high-risk activities, but it remains silent on the administrative machinery surrounding issued bills. Meanwhile, NHS England distributed Copilot to 505,000 staff members this year to assist with administration in a system that generates almost no denied claims to pursue.

Despite these targeted interventions, a broader strategic gap remains across the continent. WHO Europe noted in July that nearly two-thirds of regional nations currently utilize diagnostic AI, yet merely 8% possess a formalized health strategy for the technology.